Skip to main content

Helus Pharma Inc 6-K, filed Nov 16, 2026

Helus Pharma Inc. (HELP)

6-K 2026-11-16 For: 2026-11-16
View Original
Added on November 16, 2026

About this 6-K

Helus Pharma Inc filed this 6-K on November 16, 2026.

Helus Pharma completed enrollment in Phase 3 APPROACH for HLP003 in MDD, with topline data on track for Q4 2026. Cash totaled $171.1 million and net loss was $103.1 million for the quarter ended September 30, 2026. AI summary